Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-07

Clinical Trial Update: A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating Cybis 10:25 THC:CBD oil for chronic back/neck pain in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cybis (THC:CBD oil)

Snippet

Sponsor: Cymra Life Sciences | Conditions: Chronic Pain, Neck Pain | Phase 1, Phase 2 | Status: COMPLETED